Represented the Seattle Chinese Garden Society in regard to the early development of a four-acre Sichuan-style Chinese Garden at the South Seattle College campus in West Seattle.
Advised a U.S.-based real estate developer and asset manager in establishing its corporate organizational structure in Asia with a series of tiered, offshore and wholly-owned British Virgin Islands and Hong Kong subsidiaries.
Advised the Real Estate and Finance Program at Peking University’s School of Law on the adoption of a real estate investment trust scheme.
Negotiated, drafted and executed a join cooperation agreement for Jones Lang LaSalle China with a major Chinese international tendering company to arrange China-based financing sources of onshore and offshore real estate development projects owned by foreign development companies.
Represented the Seattle Chinese Garden Society in the development of a four-acre, Sichuan-style Chinese garden at the South Seattle College campus.
Advised Dutch company Thermoflor, BV with establishing a chain of European-styled garden centers in China.
Negotiated a Hong Kong-based joint venture arrangement and shareholders’ agreement with affiliates of a Chinese trust company and created a proprietary securities distribution network in China through structuring a series of affiliate agreements with Chinese trust companies, wealth management companies, the private banking arms of large domestic Chinese banks and securities dealers.
Negotiated and drafted a joint venture for Encore Enterprises in a collaborative agreement between Encore, Jones Lang LaSalle China and the Grand China Fund.
Advised the People’s Bank of China and the Asian Development Bank on the adoption of an asset-backed securitization scheme.
Advised Beijing Donia Resources Co. Ltd. with its investment in an iron ore mine in Goa, India.
Represented an apparel company in a capital investment by a Chinese manufacturer. Subsequently advised on licensing transactions and negotiated factoring agreements.
Mergers & Acquisitions
Formed definitive acquisition agreements for Humanwell Healthcare Group of China and PuraCap Pharmaceutical LLC to obtain all membership interests of a large generic drug company for $550 million.
Guided the sale of Pan-Pacific Enterprises, Inc., the largest independent distributor of medical x-ray tubes in China.
Represented a Chinese private equity fund and its U.S. operating subsidiary in an acquisition of a U.S.-based specialty pharmaceutical company specializing in innovative therapeutics.
Represented Chinese entertainment and media-based companies with their U.S. operations, including investments in and production of films, acquisition of media content, and investments in and acquisitions of entertainment and media-based businesses.
Obtained Chapter 7 bankruptcy approval for Hess Industries, Inc. and Hess Engineering in a sale of all assets to a Chinese-based company for more than $19 million. The transactions involved foreign buyers and required a thorough analysis of Commerce Department and ITAR issues.
Represented the U.S. subsidiary of a Taiwanese company, operating under a court-appointed receiver, in a competitive auction process for the sale of one of the nation's leading furniture retailers for approximately $100 million.
Assisted on a $19.5 million PIPE transaction with Hong Kong-based public company investors and high net worth individuals that involved two classes of convertible preferred stock and a strategic software license agreement.
Represented Shenzhen Infinova and its Hong Kong-based subsidiary Infinova International (Infinova), a leader in high definition video surveillance solutions, on its $85 million acquisition of an Australian-based security systems company specializing in the supply of surveillance and monitoring technology to the retail market.
Advised on the sale of ownership interest for a Hong Kong manufacturer of toys and entertainment items.
Advised on the formation of GC Capital LLC, a technology venture fund, and counseled its successful fund raising, subsequently moving its headquarters from the United States to Hong Kong.
Represented a Hong Kong film distributor in establishing a branch office in the U.S. and advising on distribution agreements.
Obtained necessary U.S. government approvals for GVC, a leading Taiwan computer component manufacturer, for its takeover of an American distributor and OEM manufacturer of modems and computer peripherals, as well as the takeover of BCM Advanced Research Incorporated, an American computer company.
Created and drafted an "institutional quality" offering circular for a U.S.-based real estate developer and asset manager in the sale of its EB-5 investment programs in China.
Obtained favorable settlement for an ex-Hong Kong accounting partner in a claim against a global accounting firm for breach of fiduciary duty arising out of alleged scapegoating for SEC regulatory violations.
Served as lead counsel in more than 30 anti-dumping cases involving merchandise as diverse as plywood, preserved mushrooms, magnesia carbon bricks, activated carbon, laminated woven sacks, small diameter graphite electrodes, frozen warmwater shrimp, wooden bedroom furniture, steel nails, wire decking and garlic.
Represented two major Chinese corporations in an international antitrust dispute over exports of bauxite with litigation taking place in the Western District of Pennsylvania and at the World Trade Organization.
Advised on broker-dealer compliance with international trading transactions for Tradition-Asiel Securities. Subsequently advised on the proper procedures for transferring funds and securities.
Litigated in arbitration proceedings for Chinese firms before the China International Economic and Trade Arbitration Commission (CIETAC). Disputes involved arbitration awards and enforcement in the United States.
X6D Ltd. V. Li-Tek Corp. - Obtained summary judgment of trade secret and copyright claims for a Chinese manufacturer.
Developed a pharmaceutical intermediate patent portfolio for a start up company who built one of the first FDA GMP pharmaceutical manufacturing plants in China for manufacturing its compounds.
Represented a Taiwanese computer mouse manufacturer in the first successful antitrust and IP misuse case against Microsoft. The case was widely reported in major media around the world.
Represented Acumed on a range of healthcare and privacy-related compliance matters, ranging from HIPAA and HITECH rules to Chinese compliance regulations.
Advised Limeade on a range of privacy and data security compliance matters, including HIPAA regulations, GDPR compliance, security standards and vendor management practices. Helped provide Limeade with internal compliance and security gap assessments, as well as the policies and procedures to close actual or perceived gaps to ensure compliance with Chinese and international privacy law.